Suraksha Diagnostic Ltd Stock Price Today (NSE: SURAKSHA)
Fundamental Score
Suraksha Diagnostic Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis
Suraksha Diagnostic Ltd share price today is ₹263.85, up +0.00% on NSE/BSE as of 18 March 2026. Suraksha Diagnostic Ltd (SURAKSHA) is a Small-cap company in the Healthcare Service Provider sector with a market capitalisation of ₹1.53K (Cr). The 52-week high for SURAKSHA share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 48.05x, SURAKSHA is currently trading above its industry average P/E of 39.28x. The company has a Return on Equity (ROE) of 16.46% and a debt-to-equity ratio of 0.51.
Suraksha Diagnostic Ltd Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Suraksha Diagnostic Ltd Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Suraksha Diagnostic Share Price: A Financial Analysis
In the evolving landscape of healthcare service providers, a crucial trend is the increased demand for preventative diagnostics driven by a growing awareness of proactive health management. This analysis examines the financial standing of Suraksha Diagnostic Ltd, focusing on its key metrics. Currently, the Suraksha Diagnostic share price stands at ₹288.3500061035156. This analysis is part of an 80-parameter fundamental audit verified by Sweta Mishra.
One of the first indicators of a company's health is its Price-to-Earnings (PE) ratio. Suraksha Diagnostic Ltd reports a PE of 48.05. While PE ratios vary across sectors, it's important to compare this figure to its peers. Considering
Aspira Pathlab & Diagnostics Limited, understanding the management quality and future growth prospects becomes paramount to justify a potentially higher valuation. Are the management decisions driving superior operational efficiency and market penetration compared to competitors? These factors influence investor confidence.Return on Capital Employed (ROCE) is another crucial metric. Suraksha Diagnostic Ltd exhibits a ROCE of 17.84%. This percentage illustrates how efficiently the company is generating profits from its invested capital. A strong ROCE, like the one observed here, contributes significantly to the development of a company's economic moat. Specifically, a consistent and high ROCE allows Suraksha Diagnostic to reinvest profits strategically, expanding its network of diagnostic centers, improving technology, and ultimately reinforcing its competitive advantage within the market.
Finally, a comparative analysis with sector peers such as Gian Life Care Ltd and Samsrita Labs Ltd is crucial to understanding Suraksha Diagnostic's relative position. Evaluating factors like revenue growth, profitability margins, and debt levels within this context paints a more comprehensive picture of the company's financial health and its ability to navigate the challenges and opportunities within the diagnostic services sector.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Suraksha Diagnostic Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SURAKSHA across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Return on Equity (16.46%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (17.84%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Strong Operating Margins (26.87%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Strong Revenue Growth (17.95%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Strong Profit Growth Track Record (16.38% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Strong Interest Coverage (5.39x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Strong Cash Generation (₹102.08 Cr over 5Y)
Observation: Healthy free cash flow generation supports growth and returns.
Analysis: Strong FCF provides flexibility for dividends, debt reduction, and growth investments.
Strong Institutional Confidence (FII+DII: 35.71%)
Observation: Significant professional investor participation.
Analysis: High institutional holding often signals thorough due diligence.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
4 factors identified
Premium Valuation Risk (P/E: 48.05x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-13.06%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Weak Earnings Growth (-50.98% CAGR)
Observation: Below-average 5-year EPS growth performance.
Analysis: Low EPS growth may not keep pace with inflation.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Suraksha Diagnostic Ltd Financial Statements
Comprehensive financial data for Suraksha Diagnostic Ltd including income statement, balance sheet and cash flow
About SURAKSHA (Suraksha Diagnostic Ltd)
Suraksha Diagnostic Ltd (SURAKSHA) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Healthcare Service Provider sector with a current market capitalisation of ₹1.53K (Cr). Suraksha Diagnostic Ltd has delivered a Return on Equity (ROE) of 16.46% and a ROCE of 17.84%. The debt-to-equity ratio stands at 0.51, reflecting the company's capital structure. Investors tracking SURAKSHA share price can monitor key metrics including P/E ratio, promoter holding of 48.98%, and quarterly earnings growth.
Company Details
Key Leadership
SURAKSHA Share Price: Frequently Asked Questions
What is the current share price of Suraksha Diagnostic Ltd (SURAKSHA)?
As of 18 Mar 2026, 10:28 am IST, Suraksha Diagnostic Ltd share price is ₹263.85. The SURAKSHA stock has a market capitalisation of ₹1.53K (Cr) on NSE/BSE.
Is SURAKSHA share price Overvalued or Undervalued?
SURAKSHA share price is currently trading at a P/E ratio of 48.05x, compared to the industry average of 39.28x. Based on this relative valuation, the Suraksha Diagnostic Ltd stock appears to be Overvalued against its sector peers.
What is the 52-week high and low of SURAKSHA share price?
The 52-week high of SURAKSHA share price is ₹N/A and the 52-week low is ₹N/A.
What factors affect the Suraksha Diagnostic Ltd share price?
Key factors influencing SURAKSHA share price include quarterly earnings growth (Sales Growth: 17.95%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Suraksha Diagnostic Ltd a good stock for long-term investment?
Suraksha Diagnostic Ltd shows a 5-year Profit Growth of 16.38% and an ROE of 16.46%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.51 before investing in SURAKSHA shares.
How does Suraksha Diagnostic Ltd compare with its industry peers?
Suraksha Diagnostic Ltd competes with major peers in the Healthcare Service Provider. Investors should compare SURAKSHA share price P/E of 48.05x and ROE of 16.46% against the industry averages to determine competitive standing.
What is the P/E ratio of SURAKSHA and what does it mean?
SURAKSHA share price has a P/E ratio of 48.05x compared to the industry average of 39.28x. Investors pay ₹48 for every ₹1 of annual earnings.
How is SURAKSHA performing according to Bull Run's analysis?
SURAKSHA has a Bull Run fundamental score of 47.1/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does SURAKSHA belong to?
SURAKSHA operates in the Healthcare Service Provider industry. This classification helps understand the competitive landscape and sector-specific trends affecting Suraksha Diagnostic Ltd share price.
What is Return on Equity (ROE) and why is it important for SURAKSHA?
SURAKSHA has an ROE of 16.46%, which indicates excellent management efficiency. ROE measures how efficiently Suraksha Diagnostic Ltd generates profits from shareholders capital.
How is SURAKSHA debt-to-equity ratio and what does it indicate?
SURAKSHA has a debt-to-equity ratio of 0.51, which indicates moderate leverage that should be monitored.
What is SURAKSHA dividend yield and is it a good dividend stock?
SURAKSHA offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Suraksha Diagnostic Ltd shares.
How has SURAKSHA share price grown over the past 5 years?
SURAKSHA has achieved 5-year growth rates of: Sales Growth 9.86%, Profit Growth 16.38%, and EPS Growth -50.98%.
What is the promoter holding in SURAKSHA and why does it matter?
Promoters hold 48.98% of SURAKSHA shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Suraksha Diagnostic Ltd.
What is SURAKSHA market capitalisation category?
SURAKSHA has a market capitalisation of ₹1534 crores, placing it in the Small-cap category.
How volatile is SURAKSHA stock?
SURAKSHA has a beta of N/A. A beta > 1 suggests the Suraksha Diagnostic Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is SURAKSHA operating profit margin trend?
SURAKSHA has a 5-year average Operating Profit Margin (OPM) of 26.87%, indicating the company's operational efficiency.
How is SURAKSHA quarterly performance?
Recent quarterly performance shows Suraksha Diagnostic Ltd YoY Sales Growth of 17.95% and YoY Profit Growth of -13.06%.
What is the institutional holding pattern in SURAKSHA?
SURAKSHA has FII holding of 13.73% and DII holding of 21.98%. Significant institutional holding often suggests professional confidence in the Suraksha Diagnostic Ltd stock.